Twist Bioscience Corp.

60
Hold
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US90184D1000
USD
32.81
3.11 (10.47%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Sep'24
Sep'23
Sep'22
Sep'21
Sep'20
Sep'19
No of Months
12
12
12
12
12
12
Operating Income
312.00
245.00
203.00
132.00
90.00
54.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
312.00
245.00
203.00
132.00
90.00
54.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
Operating Expenses
0.00
0.00
0.00
0.00
0.00
1.00
General and Administration Expenses
218.00
189.00
212.00
135.00
103.00
80.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
488.00
452.00
452.00
285.00
207.00
163.00
Operating Profit (PBDIT) excl Other Income
-175.00
-206.00
-249.00
-153.00
-117.00
-108.00
Other Income
12.00
13.00
6.00
0.00
1.00
2.00
Operating Profit (PBDIT)
-131.00
-163.00
-205.00
-142.00
-109.00
-99.00
Interest
0.00
0.00
0.00
0.00
0.00
1.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
31.00
29.00
36.00
11.00
6.00
6.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
-208.00
-203.00
-228.00
-154.00
-139.00
-107.00
Provision for Tax
0.00
1.00
-10.00
-1.00
0.00
0.00
Profit After Tax
-208.00
-204.00
-217.00
-152.00
-139.00
-107.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
-3.60
-3.60
-4.04
-3.15
-3.57
-3.92
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Sep 2024 is 27.69% vs 20.41% in Sep 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Sep 2024 is 14.98% vs 16.91% in Sep 2023

stock-summary

Interest

YoY Growth in year ended Sep 2024 is 480.00% vs -93.75% in Sep 2023

stock-summary

Profit After Tax

YoY Growth in year ended Sep 2024 is -2.01% vs 6.08% in Sep 2023

Compare Profit and Loss Results of Twist Bioscience Corp.
Markets Mojo
Figures in Million
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
No of Months
12
12
Operating Income
312.00
614.00
-302.00
-49.19%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
312.00
614.00
-302.00
-49.19%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
0.00
0.00
0.00
0%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
0.00
0.00
0.00
0%
Operating Expenses
0.00
33.00
-33.00
-100.00%
General and Administration Expenses
218.00
249.00
-31.00
-12.45%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
488.00
612.00
-124.00
-20.26%
Operating Profit (PBDIT) excl Other Income
-175.00
2.00
-177.00
-8,850.00%
Other Income
12.00
17.00
-5.00
-29.41%
Operating Profit (PBDIT)
-131.00
87.00
-218.00
-250.57%
Interest
0.00
33.00
-33.00
-100.00%
Profit before Depriciation and Tax
0.00
0.00
0.00
0%
Depreciation
31.00
67.00
-36.00
-53.73%
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
-208.00
-22.00
-186.00
-845.45%
Provision for Tax
0.00
-3.00
3.00
100.00%
Profit After Tax
-208.00
-18.00
-190.00
-1,055.56%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
0.00
0.00
0.00
0%
Profit Available for appropriations
0.00
0.00
0.00
0%
Appropriations
0.00
0.00
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
-3.5977
-1.0429
-2.55
-244.97%
Profit And Loss - Net Sales
Net Sales 312.97 Million
in Sep 2024

Figures in Million
stock-summary

YoY Growth in year ended Sep 2024 is 27.69% vs 20.41% in Sep 2023

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) -175.90 Million
in Sep 2024

Figures in Million
stock-summary

YoY Growth in year ended Sep 2024 is 14.98% vs 16.91% in Sep 2023

Profit And Loss - Interest
Interest 0.03 Million
in Sep 2024

Figures in Million
stock-summary

YoY Growth in year ended Sep 2024 is 480.00% vs -93.75% in Sep 2023

Profit And Loss - Profit After Tax
Profit After Tax -208.73 Million
in Sep 2024

Figures in Million
stock-summary

YoY Growth in year ended Sep 2024 is -2.01% vs 6.08% in Sep 2023